Label: SUSTAIN III CALF- sulfamethazine sustained release calf tablet, extended release

  • NDC Code(s): 61133-1333-1, 61133-1333-2
  • Packager: Bimeda, Inc.
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Animal Drug Application

Drug Label Information

Updated March 28, 2024

If you are a consumer or patient please visit this version.

  • DESCRIPTION

    Sustain III® Calf Bolus(sulfamethazine)

    SUSTAINED RELEASED BOLUS (72 HOURS) Antibacterial 

    CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. 

    NOT FOR HUMAN USE

    KEEP OUT OF REACH OF CHILDREN

    Approved by FDA under NADA # 120-615

  • INDICATIONS & USAGE

    EACH BOLUS CONTAINS: Sulfamethazine (formulated in a sustained release base), 123.8 grains (8.02 grams).

    Sustain III Calf Boluses (sulfamethazine) are intended for oral administration to ruminating replacement calves (calves over one (1) month old that are not on an all-milk diet).

    Sustain III Calf Boluses are indicated for the treatment of the following diseases when caused by one or more of the following pathogenic organisms sensitive to sulfamethazine:  Bacterial Pneumonia (Pasteurella spp.), Colibacillosis (Bacterial Scours) (E. coli) and Calf Diphtheria (Fusobacteriulm necrophorum).

  • WARNINGS

    RESIDUE WARNING: Treated animals intended for human consumption should not be slaughtered for food for at least 12 days after the last dose. Exceeding two (2) consecutive doses may cause violative tissue residues to remain beyond the withdrawal time. Do not use in calves under one (1) month of age or calves being fed an all-milk diet. Use in these classes of calves may cause violative residues to remain beyond the withdrawal time. Do not use in female dairy cattle 20 months of age or older. Use of sulfamethazine in this class of cattle may cause milk residues.

  • PRECAUTIONS

    CAUTION: This drug, like all sulfonamides, may cause toxic reactions and irreparable injury unless administered with adequate and continuous supervision. Follow recommended dosages carefully. Fluid intake must be adequate at all times throughout the three-day therapy provided by the sustained release bolus. This product has not been shown to be effective for non-ruminating calves.

  • SPL UNCLASSIFIED SECTION

    CONTACT INFORMATION: To report adverse drug events, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact Bimeda, Inc. at 1-888-524-6332. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or http://www.fda.gov/reportanimalae

  • SPL UNCLASSIFIED SECTION

    DOSAGE AND ADMINISTRATION: Sustain III Calf Boluses (sulfamethazine) are designed to be administered orally to ruminating replacement calves (See RESIDUE WARNING Statement). Sustain II Calf Boluses should be given according to the following dosage schedule.

    image description

    This bolus may be divided for better approximation of the correct dose; however, care should be taken not to crush the bolus. Care should also be taken to ensure the entire dose has been swallowed by the animal. Observe animals following the administration to ensure boluses are not regurgitated. Lubricate bolus before dosing animals.

    Sustain III Calf Boluses are designed to provide a therapeutic sulfamethazine level in approximately 6 hours, and persist in providing this level for 72 hours (3 days). After 72 hours, all animals should be re-examined for persistence of observable disease signs. If signs are present, consult a veterinarian. It is strongly recommended that a second dose be given to provide an additional 72 hours of therapy, particularly in those more severe cases. The above schedule should be used at each 72-hour interval.

  • STORAGE AND HANDLING

    Store at 20°C - 25°C (68°F - 77°F), with excursions permitted to 15°C - 30°C (59°F - 86°F).

  • PRINCIPAL DISPLAY PANEL

    image description

  • INGREDIENTS AND APPEARANCE
    SUSTAIN III CALF 
    sulfamethazine sustained release calf tablet, extended release
    Product Information
    Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:61133-1333
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Sulfamethazine (UNII: 48U51W007F) (SULFAMETHAZINE - UNII:48U51W007F) Sulfamethazine8.02 g  in 8.63 g
    Product Characteristics
    ColorblueScore2 pieces
    ShapeOVALSize13mm
    FlavorImprint Code NA
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:61133-1333-1215.75 g in 1 BOTTLE
    2NDC:61133-1333-2431.5 g in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NADANADA12061507/18/1984
    Labeler - Bimeda, Inc. (060492923)
    Registrant - Bimeda, Inc. (060492923)
    Establishment
    NameAddressID/FEIBusiness Operations
    Bimeda, Inc.060492923manufacture
    Establishment
    NameAddressID/FEIBusiness Operations
    Second Pharma Company, Ltd.527973171api manufacture
    Establishment
    NameAddressID/FEIBusiness Operations
    Nanhai Beisha Pharmaceutical Co.527929800api manufacture